| Identification | Back Directory | [Name]
MB-07133 | [CAS]
1190389-15-1 | [Synonyms]
RVT-901
KRP-114V
Vibegron-13C-D4
Vibegron (MK-4618)
(6S)-4,6,7,8-Tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxopyrrolo[1,2-a]pyrimidine-6-carboxamide
Pyrrolo[1,2-a]pyrimidine-6-carboxamide, 4,6,7,8-tetrahydro-N-[4-[[(2S,5R)-5-[(R)-hydroxyphenylmethyl]-2-pyrrolidinyl]methyl]phenyl]-4-oxo-, (6S)- | [Molecular Formula]
C26H28N4O3 | [MDL Number]
MFCD28502057 | [MOL File]
1190389-15-1.mol | [Molecular Weight]
444.53 |
| Hazard Information | Back Directory | [Uses]
Vibegron is a potent and selective β3 Adrenergic receptor agonist for the treatment of overactive bladder. | [Definition]
ChEBI: Vibegron is a pyrrolopyrimidine obtained by formal condensation of the carboxy group of (6S)-4-oxo-4,6,7,8-tetrahydropyrrolo[1,2-a]pyrimidine-6-carboxylic acid with the amino group of (R)-[(2R,5S)-5-(4-aminobenzyl)pyrrolidin-2-yl](phenyl)methanol. It is a beta3-adrenergic receptor agonist currently in clinical development for the treatment of patients with overactive bladder. It has a role as a beta-adrenergic agonist. It is a secondary alcohol, a member of pyrrolidines, a member of benzenes, a secondary carboxamide, a pyrrolopyrimidine and a secondary amine. | [storage]
4°C, away from moisture and light |
|
|